Cerebral EBV-positive PTLD controlled by PD-1 checkpoint blockade in a liver transplant patient

Affiliations

• ¹ Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
• ² Berlin Institute of Health (BIH), Berlin, Germany.
• ³ German Cancer Consortium (DKTK), Berlin, Germany.
• ⁴ Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
• ⁵ Department of Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
• ⁶ Institute of Neuroradiology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
• ⁷ Institute of Pathology, University of Würzburg, Würzburg, Germany.
• ⁸ Experimental and Clinical Research Center (ECRC), Berlin, Germany.
• ⁹ BIH Centre for Regenerative Therapies, Berlin, Germany.
• ¹⁰ Cluster of Excellence, NeuroCure, Berlin, Germany.
• ¹¹ German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
• ¹² Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
• ¹³ Department of Hematology and Oncology, Kepler University Hospital, Johannes Kepler University, Linz, Austria.